Skip navigation
Universidade Federal da Bahia |
Repositório Institucional da UFBA
Use este identificador para citar ou linkar para este item: https://repositorio.ufba.br/handle/ri/41266
Registro completo de metadados
Campo DCValorIdioma
dc.creatorRamos, Leila Valverde-
dc.date.accessioned2025-02-18T13:27:39Z-
dc.date.available2025-02-18T13:27:39Z-
dc.date.issued2025-02-10-
dc.identifier.citationRamos, Leila Valverde. Análise descritiva do perfil clínico de adultos com doença falciforme em hospital público. Orientador: Roberto Paulo Correia de Araújo. 2025. 169 f. Tese (Doutorado em Processos Interativos dos Órgãos e Sistemas) - Instituto de Ciências da Saúde, Universidade Federal da Bahia, Salvador, 2025.pt_BR
dc.identifier.urihttps://repositorio.ufba.br/handle/ri/41266-
dc.description.abstractIntroduction – Sickle cell disease (SCD) is a genetic disorder predominantly affecting black and brown individuals, with high prevalence and incidence. Erythrocytes containing hemoglobin S (HbS) assume a sickle-like shape, which can lead to tissue damage in various organs, frequently accompanied by pain, physical-functional impairments, and emotional, social, and occupational losses. In this context, further studies are necessary to gain a more comprehensive understanding of SCD, its associated complications, and its potential biopsychosocial impact. Objective – To assess the clinical, physical-functional, and emotional aspects of adults with SCD receiving care at a public referral hospital in Salvador, Bahia. Materials and Methods – Thirty-eight adults with SCD participated in this quantitative, descriptive, and cross-sectional study, conducted between May and December 2024. The clinical profile was established through a detailed anamnesis, which included sociodemographic characteristics, pain assessment using the Visual Analog Scale (VAS) and the Brief Pain Inventory (BPI), and the application of the Short Form Health Survey (SF-36), the Hospital Anxiety and Depression Scale (HADS), and the PROMIS Fatigue-Short Form v1.0-Fatigue 7A (PROMIS F-SF). Descriptive statistical analyses were performed using R software. Results: The sample exhibited an equitable gender distribution and a mean age of 33.5 years. The majority were single (65.8%), Black (55.3%) or mixed-race (42.1%), had completed high school (50%), and reported a monthly family income of up to one minimum wage (71.1%). The predominant SCD genotypes were HbSS (71.1%) and HbSC (28.9%). All participants (100%) experienced chronic pain, and 94.8% had femoral head osteonecrosis (FHO). Moderate pain intensity (VAS) was reported by 44.7%, with severe impacts on daily life (IBD) observed in 60% of cases. Symptoms suggestive of anxiety were identified in 34.2% of participants, while 26.3% screened positive for depression (HADS). Additionally, 69.6% reported moderate fatigue (PROMIS F S-F), and physical health domains were notably impaired, indicating a compromised health-related quality of life (HRQoL) (SF-36). Conclusion: This study underscores the relevance of assessment tools in the diagnosis, monitoring, and management of SCD, highlighting its significant biopsychosocial impacts. These findings contribute to the scientific literature and may inform more effective clinical practices for individuals with SCD.pt_BR
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)pt_BR
dc.languageporpt_BR
dc.publisherUniversidade Federal da Bahiapt_BR
dc.rightsAcesso Abertopt_BR
dc.subjectDoença falciformept_BR
dc.subjectAnemia Falciformept_BR
dc.subjectDorpt_BR
dc.subjectFadigapt_BR
dc.subjectPerfil de saúdept_BR
dc.subjectQualidade de vidapt_BR
dc.subject.otherSickle cell diseasept_BR
dc.subject.otherAnemia, Sickle Cellpt_BR
dc.subject.otherPainpt_BR
dc.subject.otherFatiguept_BR
dc.subject.otherHealth profilept_BR
dc.subject.otherQuality of lifept_BR
dc.titleAnálise descritiva do perfil clínico de adultos com doença falciforme em hospital públicopt_BR
dc.title.alternativeDescriptive analysis of the clinical profile of adults with sickle cell disease in a public hospitalpt_BR
dc.typeTesept_BR
dc.publisher.programPrograma de Pós-Graduação em Processos Interativos dos Órgãos e Sistemas (PPGORGSISTEM) pt_BR
dc.publisher.initialsUFBApt_BR
dc.publisher.countryBrasilpt_BR
dc.subject.cnpqCNPQ::CIENCIAS DA SAUDEpt_BR
dc.contributor.advisor1Araújo, Roberto Paulo Correia de-
dc.contributor.advisor1Latteshttp://lattes.cnpq.br/8389914651900629pt_BR
dc.contributor.referee1Araújo, Roberto Paulo Correia de-
dc.contributor.referee1Latteshttp://lattes.cnpq.br/8389914651900629pt_BR
dc.contributor.referee2Fernandes, Atson Carlos de Souza-
dc.contributor.referee2Latteshttp://lattes.cnpq.br/8458546406023605pt_BR
dc.contributor.referee3Matta, Mônica Cardoso da-
dc.contributor.referee3Latteshttp://lattes.cnpq.br/8924940250426984pt_BR
dc.contributor.referee4Ribeiro, Marcos Borges-
dc.contributor.referee4Latteshttp://lattes.cnpq.br/7634265862645053pt_BR
dc.contributor.referee5Rossi, Marcelle Alvarez-
dc.contributor.referee5Latteshttp://lattes.cnpq.br/6170734502678596pt_BR
dc.creator.IDhttps://orcid.org/0000-0002-3128-0012pt_BR
dc.creator.Latteshttps://lattes.cnpq.br/1531015910988111pt_BR
dc.description.resumoIntrodução – A doença falciforme (DF) é uma patologia genética, predominante em pessoas pretas e pardas, com alta prevalência e incidência. As hemácias com hemoglobina S (HbS) apresentam formato similar à foice, que podem causar lesões teciduais de órgãos, frequentemente, acompanhadas de dor, perdas físico-funcionais, emocionais, sociais e laborais. Nesse contexto, estudos são necessários para conhecer mais detalhadamente a DF, as complicações associadas e os prováveis impactos biopsicossociais. Objetivo – Avaliar os aspectos clínicos, físico-funcionais e emocionais de adultos com DF atendidos em um hospital público de referência na cidade de Salvador, Bahia. Materiais e métodos – Trinta e oito adultos com DF participaram desse estudo quantitativo, descritivo e transversal, no período entre maio e dezembro de 2024. O perfil clínico foi traçado mediante anamnese detalhada, que incluiu a descrição dos aspectos sociodemográficos; avaliação da dor por meio da Escala Visual Analógica (EVA) e do Inventário Breve da Dor (IBD); aplicação do questionário Short Form Health Survey (SF-36), da escala Hospital Anxiety and Depression Scale (HADS), e do questionário PROMIS Fatigue-Short Form v1.0-Fatigue 7A (PROMIS F-SF). As análises estatísticas descritivas foram realizadas pelo Software R. Resultados – A amostra apresentou distribuição de gênero equitativa e idade média de 33,5 anos. Majoritariamente solteiros (65,8%), pretos (55,3%) e pardos (42,1%), com ensino médio completo (50%), renda familiar mensal de até um salário mínimo (71,1%), DF do tipo HbSS (71,1%) e HbSC (28,9%), presença de dores crônicas (100%) e osteonecrose da cabeça femoral (OCF) (94,8%). 44,7% exibiram intensidade de dor moderada (EVA) com graves impactos na vida diária (IBD) (60%); 34,2% tiveram suspeita de ansiedade e 26,3% de depressão (HADS); 69,6% apresentaram fadiga moderada (PROMIS F S-F); e valores reduzidos para os aspectos físicos, indicando comprometimento da qualidade de vida relacionada à saúde (QVRS) (SF-36). Conclusão – O estudo destaca a relevância dos instrumentos de avaliação no diagnóstico, acompanhamento e manejo da DF, evidenciando impactos biopsicossociais significativos. Esses achados podem subsidiar a literatura científica e orientar práticas clínicas mais efetivas para pacientes com DF.pt_BR
dc.publisher.departmentInstituto de Ciências da Saúde - ICSpt_BR
dc.relation.references1. Pauling L, Itano HA, Singer SJ, Wells IC. Sickle cell anemia, a molecular disease. Science. 1949;109(2835):443. Doi: 10.1126/science.110.2865.543 2. Ministério da Saúde (BR). Portaria conjunta n.º 05, de 19 de fevereiro de 2018. Aprova o Protocolo Clínico e Diretrizes Terapêuticas da Doença Falciforme. Brasília: Ministério da Saúde [Internet]. 2018 [cited 2024 Apr 22]. Available from: https://bvsms.saude.gov.br/bvs/saudelegis/sas/2018/poc0005_22_02_2018.html#:~:text =Aprova%20o%20Protocolo%20Cl%C3%ADnico%20e%20Diretrizes%20Terap%C3 %AAuticas%20da%20Doen%C3%A7a%20Falciforme 3. Kavanagh PL, Fasipe TA, Wun T. Sickle cell disease: a review. JAMA. 2022;328(1):57-68. Doi:10.1001/jama.2022.10233 4. O`Brien EC, Ali S, Chevassut T. Sickle cell disease: an update. Clin Med. 2022;22(3):218-20. Doi:10.7861/clinmed.2022-0143 5. Ingram VM. A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin. Nature. 1956;13;178(4537):792-4. Doi: 10.1038/178792a0 6. Osunkwo I, Manwani D, Kanter J. Current and novel therapies for the prevention of vaso-occlusive crisis in sickle cell disease. Ther Adv Hematol. 2020;11:2040620720955000. Doi:10.1177/2040620720955000 7. Ministério da Saúde (BR). Secretaria de Atenção à Saúde. Departamento de Atenção Especializada Doença falciforme: úlceras: prevenção e tratamento [Internet]. Brasília: Ministério da Saúde; 2012a [cited 2024 May 12]. Available from: https://www.nupad.medicina.ufmg.br/wp-content/uploads/2016/12/Manual-DoencaFalciforme-Ulceras-tratamento-e-prevencao.pdf 8. Delaney KM, Axelrod KC, Buscetta A, Hassell KL, Adams-Graves PE, Seamon C, et al. Leg ulcers in sickle cell disease: current patterns and practices. Hemoglobin. 2013;37(4):325-32. Doi:10.3109/03630269.2013.789968 9. Ministério da Saúde (BR). Secretaria de Atenção à Saúde. Departamento de Atenção Hospitalar e de Urgência. Doença falciforme: enfermagem nas urgências e emergências: a arte de cuidar [Internet]. Brasília: Ministério da Saúde; 2014 [cited 2024 May 22]. Available from: https://www.nupad.medicina.ufmg.br/wpcontent/uploads/2016/12/Enfermagem-nas-Urgencias-e-Emergencias-A-arte-decuidar.pdf 10. Neumayr LD, Hoppe CC, Brown C. Sickle cell disease: current treatment and emerging therapies. Am J Manag Care [Internet]. 2019 [cited 2024 Mar 25];25(18):S335- 103 43. Available from: https://www.ajmc.com/view/sickle-cell-disease-current-treatmentand-emerging-therapies 11. Madu A, Madu K, Anigbogu I, Ugwu AO, Okwulehie VA, Ololo U, et al. Phenotypic characterisation and associations of leg ulcers in adult sickle cell patients. Wound Repair Regen. 2022;30(1):126-31. Doi:10.1111/wrr.12970 12. Jensen MP, Karoly P, Braver S. The measurement of clinical pain intensity: a comparison of six methods. Pain. 1986;27(1):117-26. Doi:10.1016/0304-3959(86)90228- 9 13. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap [Internet]. 1994 [cited 2024 Oct 20].;23(2):129-38. Available from: https://europepmc.org/article/med/8080219 14. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-370. Doi:10.1111/j.1600-0447.1983.tb09716.x 15. Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR. Tradução para a língua portuguesa e validação do questionário geral de avaliação de qualidade de vida SF-36 (Brasil SF-36). Rev Bras Reumatol [Internet]. 1999 [cited 2024 July 15];39(3):143-50. Available from: https://toneurologiaufpr.wordpress.com/wpcontent/uploads/2013/03/questionc3a1rio-de-qualidade-de-vida-sf36-traduc3a7c3a3o-evalidac3a7c3a3o.pdf 16. Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B, et al. The PatientReported Outcomes Measurement Information System (PROMIS): Progress of an NIH Roadmap Cooperative Group During Its First Two Years. Medical Care. 2007;45(5):S3- S11. Doi: 10.1097/01.mlr.0000258615.42478.55 17. Pecker LH, Lanzkron S. Sickle cell disease. Ann Intern Med. 2021;174(1):ITC1-16. Doi:10.7326/AITC202101190 18. Ministério da Saúde (BR). Secretaria de Atenção Especializada a Saúde. Departamento de Atenção Especializada e Temática. Saúde Escolar na Doença Falciforme: um olhar às crianças e adolescentes com doença falciforme [Internet]. Brasília: Editora do Ministério da Saúde; 2024 [cited 2025 Jan 10]. Available from: https://seduc.se.gov.br/download/saude-escolar-na-doenca-falciforme-um-olhar-ascriancas-e-adolescentes-com-doenca-falciforme/ 19. Ministério da Saúde (BR). Doença Falciforme: Conhecer para cuidar. Brasília: Ministério da Saúde [Internet]. 2015 [cited 2024 Apr 22]. Available from: https://telelab.aids.gov.br/moodle/pluginfile.php/39506/mod_resource/content/4/Doenca %20Falciforme_SEM.pdf 104 20. Paiva MM, Gomes SC. Acometimentos auditivos em pacientes portadores da doença falciforme. Rev Ft. 2023;27(127):1-15. Doi: 10.5281/zenodo.10066856 21. Ashorobi D, Ramsey A, Yarrarapu SNS, Bhatt R. Sickle Cell Trait. In: StatPearls. Treasure Island (FL): StatPearls Publishing [Internet]. 2022 [cited 2024 Apr 22]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537130/ 22. Thomson AM et al. GBD 2021 Sickle Cell Disease Collaborators. Global, regionaland national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Haematol. 2023;10(8):e585-e599. Doi:10.1016/S2352-3026(23)00118-7 23. Accioly J. Anemia falciforme – apresentação de um caso com infantilismo [Internet]. Tertúlias Acadêmicas, Arquivo da Universidade da Bahia. Salvador: Faculdade de Medicina da Bahia; 1947 [cited 2024 June 20];2:169-98. Available from: https://periodicos.ufba.br/index.php/arqmedicina/article/view/56069/29697 24. World Health Organization – WHO. Sickle-cell anaemia. Report by the Secretariat Fifty-ninth World Health Assembly A59/9 [Internet]. 2006 [cited 2024 June 20]. Available from: https://apps.who.int/gb/ebwha/pdf_files/WHA59/A59_9-en.pdf 25. Cançado RD, Costa FF, Lobo C, Migliavaca CB, Falavigna M, Souza Filho HC, et al. Estimated mortality rates of individuals with sickle cell disease in Brazil: real-world evidence. Blood Advances. 2023;7(15):3783-92. Doi:10.1182/bloodadvances.2022008938 26. Instituto de Pesquisa Econômica Aplicada- IPEA (BR). Seção 04 - Os níveis de escolaridade no setor público brasileiro [Internet]. Brasília: IPEA; 2017 [cited 2024 Apr 22]. Available from: https://www.ipea.gov.br/atlasestado/arquivos/rmd/4874- conjunto4v10.html#:~:text=O%20n%C3%ADvel%201%20compreende%20as,compree nde%20pessoas%20com%20alguma%20p%C3%B3s 27. Ministério da Saúde (BR). Secretaria de Atenção à Saúde. Departamento de Atenção Especializada. Doença falciforme: condutas básicas para tratamento [Internet]. Brasília: Ministério da Saúde; 2012b [cited 2024 Jun 22]. (Série B, Textos Básicos de Saúde). Available from: https://bvsms.saude.gov.br/bvs/publicacoes/doenca_falciforme_condutas_basicas.pdf 28. Instituto Brasileiro de Geografia e Estatística – IBGE. Censo Demográfico 2022: Identificação étnico-racial da população, por sexo e idade: Resultados do universo [Internet]. 2022 [cited 2024 Feb 15]. Available from: https://censo2022.ibge.gov.br/panorama/indicadores.html?localidade=BR&tema=2 29. Silva WS, Oliveira RF, Ribeiro SB, Silva IB, Araújo EM, Baptista AF. Screening for structural hemoglobin variants in Bahia, Brazil. Int J Environ Res Saúde Pública. 2016;13(2):225. Doi: 10.3390/ijerph13020225 105 30. Ramos LV, Araújo RPC. Perfil epidemiológico dos óbitos por doença falciforme no estado da Bahia, Brasil (2013-2022). Anais do Congresso On-line Nacional de Saúde Multidisciplinar (Conasmulti) - 3ª edição. Doi: 10.53524/lit.edt.978-65-84528-37-6/33 31. Braga JA. Medidas gerais no tratamento das doenças falciformes. Hematol Transfus Cell Ther. 2007;29:233-38. Doi: 10.1590/S1516-84842007000300009 32. Pulte D, Riddick-Burden G, Ballas SK. Characteristics of “older old" patients with sickle cell anemia who survived for more than 80 years. Blood. 2015;126(23):4599. Doi: 10.1182/blood.V126.23.4599.4599 33.Hamamy HA, Al-Allawi NA. Epidemiological profile of common haemoglobinopathies in Arab countries. J Community Genet. 2013;4(2):147-67. Doi:10.1007/s12687-012-0127-8 34. Laghdaf Sidi M, N'Diaye AM, Cheikh M, Heinhane MM. Sickle Cell Disease in Mauritania: epidemiological, clinical and therapeutic aspects about 135 cases. Tunis Med [Internet]. 2022 [cited 2024 Feb 12];100(4):313-22. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486954/ 35. Junqueira LC, Carneiro J. Histologia básica I Junqueira & Carneiro. 12. ed. Rio de Janeiro: Guanabara Koogan; 2013 36. Kumar V, Abbas AK, Aster JC. Robbins Patologia Básica. 10. ed. Rio de Janeiro: Guanabara Koogan; 2018 37. Mandal AK, Mitra A, Das R. Sickle cell hemoglobin. Subcell biochem. 2020;94:297- 322. Doi:10.1007/978-3-030-41769-7_12 38. Sundd P, Gladwin MT, Novelli EM. Pathophysiology of sickle cell disease. Annu Rev Pathol. 2019;14:263-92. Doi:10.1146/annurev-pathmechdis-012418-012838 39. Loggetto SR, Veríssimo MPA, Darrigo-Junior LG, Simões R, Bernardo WM, Braga JAP. Guidelines on sickle cell disease: secondary stroke prevention in children and adolescents. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular guidelines project: Associação Médica Brasileira - 2022. Hematol Transfus Cell Ther. 2022;44(2):246-55. Doi:10.1016/j.htct.2022.01.010 40. Felix AA, Helio MS, Ribeiro SBF. Aspectos epidemiológicos e sociais da doença falciforme. Rev Bras Hematol Hemoter. 2010;32:203-8. Doi: 10.1590/S1516- 84842010005000072 41. Kirkham JK, Estepp JH, Weiss MJ, Rashkin SR. Genetic variation and sickle cell disease severity: A systematic review and meta-analysis. JAMA Netw Open. 2023;6(10):e2337484. Doi: 10.1001/jamanetworkopen.2023.37484 106 42. Onimoe G, Rotz S. Sickle cell disease: a primary care update. Cleve Clin J Med. 2020;87(1):19-27. Doi:10.3949/ccjm.87a.18051 43. Manley AF. Legislation and funding for sickle cell services, 1972-1982. Am J Pediatr Hematol Oncol [Internet]. 1984 [cited 2024 Jul 25]. Spring;6(1):67-71. Available from: https://journals.lww.com/jphoonline/abstract/1984/00610/Legislation_and_funding_for_sickle_cell_services,.12.aspx 44. Ministério da Saúde (BR). Portaria nº 1.391/GM, de 16 de agosto de 2005. Institui, no âmbito do Sistema Único de Saúde - SUS, como diretrizes para a Política Nacional de Atenção Integral às Pessoas com Doença Falciforme e outras Hemoglobinopatias [Internet]. Brasília: Ministério da Saúde (BR); 2005 [cited 2023 Dez 12]. Diário Oficial da União (1391). Available from: https://bvsms.saude.gov.br/bvs/saudelegis/gm/2005/prt1391_16_08_2005.html 45. Adorno, EV. Como é feito o diagnóstico da doença falciforme? Fiocruz Bahia [Internet]. 2020 [cited 2024 Aug 8]. Available from: https://www.youtube.com/watch?v=mMuaYfza-lQ 46. Ministério da Saúde (BR). Portaria nº 822, de 06 de junho de 2001. Institui no âmbito do Sistema Único de Saúde, o Programa Nacional de Triagem Neonatal / PNTN [Internet]. Brasília: Ministério da Saúde; 2001 [cited 2024 June 20]. Available from: http://bvsms.saude.gov.br/bvs/saudelegis/gm/2001/prt0822_06_06_2001.html 47. Ministério da Saúde(BR). Portaria GM/MS nº 1.459, de 24 de junho de 2011. Institui, no âmbito do Sistema Único de Saúde - SUS - a Rede Cegonha [Internet]. Brasília: Ministério da Saúde; 2011 [cited 2024 May 15]. Available from: https://bvsms.saude.gov.br/bvs/saudelegis/gm/2011/prt1459_24_06_2011.html 48. Mason SF, Dasgupta M, Flynn KE, Simpson PM, Singh A. Comparison of CAT and short forms for PROMIS pain and physical health domains in children with sickle cell disease. J Patient Rep Outcomes. 2023;7(1):12. Doi: 10.1186/s41687-023-00553-3 49. Al-Samkari H, Van Beers EJ, Morton DH, Eber SW, Chonat S, Kuo KHM, et al. Health-related quality of life and fatigue in children and adults with pyruvate kinase deficiency. Blood Adv. 2022;6(6):1844-53. Doi: 10.1182/bloodadvances.2021004675 50. McClish DK, Smith WR, Dahman BA, Levenson JL, Roberts JD, Penberthy LT, et al. Pain site frequency and location in sickle cell disease: the PiSCES project. Pain. 2009 Sep;145(1-2):246-51. Doi: 10.1016/j.pain.2009.06.029 51. Traoré C, Kyelem CG, Semdé A, Koulidiati J, Sanou AF, Bokoum S, Kafando E. Prevalence of chronic complications of sickle cell disease at the Bobo-Dioulasso Teaching Hospital, Burkina Faso. Bull Soc Pathol Exot. 2020;113(1):5-11. Doi: 10.3166/bspe-2020-0112 107 52. Václavů L, Petr J, Petersen ET, Mutsaerts HJMM, Majoie CBL, Wood JC, et al. Cerebral oxygen metabolism in adults with sickle cell disease. Am J Hematol. 2020;95(4):401-12. Doi: 10.1002/ajh.25727 53. Fox CK, Leykina L, Hills NK, Kwiatkowski JL, Kanter J, Strouse JJ, et al. Hemorrhagic stroke in children and adults with sickle cell anemia: The Post-STOP cohort. Stroke. 2022;53(11):e463-e466. Doi:10.1161/STROKEAHA.122.038651 54. Daltro G, Franco BA, Veiga D, Faleiro T, Lima V, Vitório F, et al. Desenvolvimento de Osteonecrose pós infecção por Covid-19. J Regen Biol Med. 2021;3(5)1-8. Doi: 10.37191/Mapsci-2582-385X-3(5)-087 55. Botelho V L, Silva ICF, Daltro PB, Silva ICF, Guimarães JMM. Prevalence of femoral head ostenecrosis in patients with falciform anemia: a bibliographic review in pediatrics. Int J Pediatr Res. 2020;6:064. Doi: 10.23937/2469-5769/1510064 56. Daltro G, Alencar DFD, Sobrinho UB, Guedes A, Fortuna VA. Osteonecrose da cabeça femoral na anemia falciforme. Gaz méd Bahia. 2010;3:26. Available from: https://gmbahia.ufba.br/index.php/gmbahia/article/viewFile/1107/1063 57. Miyahara HS, Ranzoni LV, Ejnisman L, Vicente JRN, Croci AT, Gurgel HMC. Osteonecrosis of the femoral head: Update article. Rev Bras Ortop. 2022;57(3):351-9. Doi: 10.1055/s-0041-1736308 58. Abbade LPF, Fradeb MAC, Pegasc JRP, Dadalti‐Granjaf P, Garciag LC, Filhoh RB, et al. Consenso sobre diagnóstico e tratamento das úlceras crônicas de perna – Sociedade Brasileira de Dermatologia. Anais Brasileiros de Dermatologia. 2020;95:1-18. Doi: 10.1016/j.abdp.2020.06.003 59. Souza VR, Kelly S, Cerdeira Sabino E, Oliveira FM, Silva T, Teixeira CM, et al. Factors associated with leg ulcers in adults with sickle cell disease in Brazil. Adv Skin Wound Care. 2023;36(2):98-105. Doi:10.1097/01.ASW.0000911152.41719.e5 60. Halabi-Tawil M, Lionnet F, Girot R, Bachmeyer C, Lévy PP, Aractingi S. Sickle cell leg ulcers: a frequently disabling complication and a marker of severity. Br J Dermatol. 2008;158(2):339-44. Doi: 10.1111/j.1365-2133.2007.08323.x 61. Sahu T, Verma HK, Ganguly S, Sinha M, Sinha R. Common, but neglected: A comprehensive review of leg ulcers in sickle cell disease. Adv Skin Wound Care. 2021;34(8):423-31. Doi: 10.1097/01.ASW.0000755924.12513.40 62. Levenson JL, McClish DK, Dahman BA, Bovbjerg VE, Citero VA, Penberthy LT, et al. Depression and anxiety in adults with sickle cell disease: the PiSCES project. Psychosom Med. 2008;70(2):192-6. Doi: 10.1097/PSY.0b013e31815ff5c5 108 63. Al-Marzouki AF, Alrefaie NI, Aljohani NA, Alandanusi RA, Alghamdi AA, Radhwi OO. The prevalence of depression and anxiety among sickle cell disease patients in King Abdulaziz University Hospital. Cureus. 2021;29;13(9):e18374. Doi: 10.7759/cureus.18374 64. Araujo Junior JA, Antonelli Rossi DA, Carneiro Valadão TF, Milan-Mattos JC, Catai AM, Sato TO, et al. Cardiovascular benefits of a home-based exercise program in patients with sickle cell disease. PLoS One. 2021;16(5):e0250128. Doi:10.1371/journal.pone.0250128 65. Martin C, Pialoux V, Faes C, Charrin E, Skinner S, Connes P. Does physical activity increase or decrease the risk of sickle cell disease complications? Br J Sports Med. 2018;52(4):214-8. Doi: 10.1136/bjsports-2015-095317 66. Kazak A, Ozkaraman A. The effect of progressive muscle relaxation exercises on pain on patients with sickle cell disease: randomized controlled study. Pain Manag Nurs. 2021;22(2):177-83. Doi:10.1016/j.pmn.2020.02.069 67. Zanoni CT, Galvão F, Maria RM, Zulli R, Ricciardi JB, Junior CA, et al. Effectiveness of a home-based therapeutic exercise program on lower back pain and functionality in Sickle Cell Disease (SCD) patients. Hematol Transfus Cell Ther. 2021;43(3):268-79. Doi: 10.1016/j.htct.2020.05.004 68. Carvalho-Siqueira GQ, Ananina G, Souza BB, Borges MG, Ito MT, Silva-Costa SM, et al. Whole-exome sequencing indicates FLG2 variant associated with leg ulcers in Brazilian sickle cell anemia patients. Exp Biol Med (Maywood). 2019;244(11):932-9. Doi:10.1177/1535370219849592 69. Antwi-Boasiako C, Andemariam B, Colombatti R, Asare EV, Strunk C, Piccone CM, et al. A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis. Ann Hematol. 2020;99(9):2073-79. Doi:10.1007/s00277-020-04057-8 70. Mendes RS, Oliveira DB. Equipe multidisciplinar no cuidado à pessoa com doença falciforme. Hematol Transfus Cell Ther. 2024;46: S1193. Doi: 10.1016/j.htct.2024.09.2087 71. Ballas SK, Barton FB, Waclawiw MA, Swerdlow P, Eckman JR, Pegelow CH, et al. Hydroxyurea and sickle cell anemia: effect on quality of life. Health Qual Life Outcomes. 2006;4:59. Doi: 10.1186/1477-7525-4-59 72. Al Zahrani OS, Mukhtar O, Al Subaie M, Al Howiti WE. Systematic psychiatric assessment of patients with sickle cell disease. Saudi Med J. 2019;40(1):59-65. Doi: 10.15537/smj.2019.1.22919 109 73. Brandow AM, Liem RI. Advances in the diagnosis and treatment of sickle cell disease. J Hematol Oncol Internet. 2022;15(1):20. Doi:10.1186/s13045-022-01237-z 74. Darbari DS, Sheehan VA, Ballas SK. The vaso-occlusive pain crisis in sickle cell disease: Definition, pathophysiology, and management. Eur J Haematol. 2020;105(3):237-46. Doi:10.1111/ejh.13430 75. Karafin MS, Singavi A, Hussain J, Wandersee N, Heinrich T, Hurley RW, et al. Predictive factors of daily opioid use and quality of life in adults with sickle cell disease. Hematology. 2018;23(10):856-63. Doi: 10.1080/10245332.2018.1479997 76. Abrams DI, Couey P, Dixit N, Sagi V, Hagar W, Vichinsky E, et al. Effect of inhaled cannabis for pain in adults with sickle cell disease: a randomized clinical trial. JAMA Netw Open. 2020;3(7):e2010874. Doi:10.1001/jamanetworkopen.2020.10874 77. Coleman B, Ellis-Caird H, McGowan J, Benjamin MJ. How sickle cell disease patients experience, understand and explain their pain: An Interpretative Phenomenological Analysis study. Br J Health Psychol. 2016;21(1):190-203. Doi:10.1111/bjhp.12157 78. Secretaria Municipal da Saúde de São Paulo (BR). Linha de cuidados em Doença Falciforme na Atenção Básica [Internet]. São Paulo: Secretaria Municipal da Saúde de São Paulo; 2021 [cited 2024 June 12]. Available from: https://www.prefeitura.sp.gov.br/cidade/secretarias/upload/saude/Manual_Anemia_Falc iforme3_14_5_2021.pdf 79. Chou ST, Alsawas M, Fasano RM, Field JJ, Hendrickson JE, Howard J. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv. 2020;4(2):327-55. Doi:10.1182/bloodadvances.2019001143 80. Lacerda FKL, Ferreira SL, Nascimento ERD, Costa DO, Cordeiro RC. Self-care deficits in women with leg ulcers and sickle cell disease. Rev Bras Enferm. 2019;72(3):72-8. Doi:10.1590/0034-7167-2018-0005 81. Wonkam A, Mba CZ, Mbanya D, Ngogang J, Ramesar R, Angwafo FF. Psychosocial stressors of sickle cell disease on adult patients in Cameroon. J Genet Couns. 2014;23:948-56. Doi: 10.1007/s10897-014-9701-z 82. Holdford D, Vendetti N, Sop DM, Johnson S, Smith WR. Indirect economic burden of sickle cell disease. Value Health. 2021;24(8):1095-101. Doi: 10.1016/j.jval.2021.02.014 83. Oliveira LAB, Lopes TS, Sousa JN, Souza AC, Baptista AF, Sousa HFP, et al. Religiosity, anxiety, depression, and suicidal ideation in brazilian patients with sickle cell disease. Reflexus. 2023;17(2):277-90. Doi: 10.20890/reflexus.v17i2.2769 110 84. Darbari DS, Brandow AM. Pain-measurement tools in sickle cell disease: where are we now? Hematology Am Soc Hematol Educ Program. 2017(1):534-41. Doi: 10.1182/asheducation-2017.1.534 85. Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology. 1997;48(2):332-8. Doi:10.1212/wnl.48.2.332 86. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN-4). Pain. 2005;114(1-9):29-36. Doi: 10.1016/j.pain.2004.12.010 87. Martinez JEM, Fujiki RHM. Criação e validação de um diário de dor para acompanhamento de dor musculoesquelética crônica no Conjunto Hospitalar de Sorocaba. Rev Fac Ciênc Méd Sorocaba. In: 32º Congresso da SUMEP [Internet]; 2015 [cited 2024 Sep 15]. Available from: http://revistas.pucsp.br/index.php/RFCMS/rt/printerFriendly/24914/0 88. Antunes FD, Silva Junior CL, Cerqueira KS, Faro LM, Cipolotti R. Screening for neuropathic pain in patients with sickle cell disease: is a single assessment scale sufficient? Orphanet J Rare Dis. 2019;14(1):108. Doi:10.1186/s13023-019-1082-9 89. Carvalho AB, Garcia JBS, Silva TKM, Ribeiro JVF. Translation and transcultural adaptation of Pain Quality Assessment Scale (PQAS) to brazilian version. Rev Bras Anestesiol. 2016;66(1):94-104. Doi: 10.1016/j.bjane.2013.10.018 90. Pimenta CAM; Teixeira, MJ. Questionário de dor McGill: proposta de adaptação para a língua portuguesa. Rev Esc Enferm USP. 1996;30(3):473-83. Doi:10.1590/S0080- 62341996000300009 91. Keller S, Bann CM, Dodd SL, Schein J, Mendoza TR, Cleeland CS. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain. 2004;20(5):309-18. Doi: 10.1097/00002508-200409000-00005 92. Driscoll J, Bamne M, Jonassaint C. Assessing the validity of the brief pain inventory for use among adults with sickle cell disease. Blood. 2017;130, 5579. Doi: 10.1182/blood.V130.Suppl_1.5579.5579 93. Wilkie DJ, Molokie R, Boyd-Seal D, Suarez MS, Kim JOK, Zong E, et al. Patientreported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease. J Natl Med Assoc. 2010;102(1):18-27. Doi:10.1016/s0027-9684(15)30471-5 111 94. O'Brien JA, Drake JA, Bearden DJ, Ono KE, Sil S, Cohen LL, et al. Cognitive considerations for adults with sickle cell disease completing the brief pain inventory. Pain Rep. 2025;9;10(1):e1189. Doi: 10.1097/PR9.0000000000001189 95. Zempsky WT, Stevens MC, Santanelli JP, Gaynor AM, Khadka S. Altered functional connectivity in sickle cell disease exists at rest and during acute pain challenge. Clin J Pain. 2017;33(12):1060-70. Doi:10.1097/AJP.0000000000000492 96. Vitorino CF, Silva NCOV, Alfieri FM. Utilização da algometria e termografia infravermelha como instrumentos de avaliação da dor: uma revisão sistemática. Acta Fisiátr. 2023;30(2):129-35. Doi: 10.11606/issn.23170190.v30i2a1782378 97. Oliveira NC, Silva KR, Santos AC, Alfieri FM. Reproducibility and reliability of pressure algometry: are digital and analogue devices comparable?. BrJP. 2024;7:e20240055. Doi: 10.5935/2595-0118.20240055-en 98. Lima KTLL, Pereira JOF, Reis PRM, Alcântara KC, Rodrigues FM. Quality of life of sickle cell disease carriers. J Nurs. 2019;13(2):424-30. Doi: 10.5205/1981-8963- v13i02a237424p424-430-2019 99. Ohara DG, Ruas G, Castro SS, Martins PR, Walsh IA. Musculoskeletal pain, profile and quality of life of individuals with sickle cell disease. Rev Bras Fisioter. 2012;16(5):431-8. Doi:10.1590/s1413-35552012005000043 100. Al Jaouni SK, Al Muhayawi MS, Halawa TF, Al Mehayawi MS. Treatment adherence and quality of life outcomes in patients with sickle cell disease. Saudi Med J [Internet]. 2013 [cited 2024 Nov 23].;34(3):261-265. Available from: https://smj.org.sa/content/smj/34/3/261.full.pdf 101. Connolly ME, Bills SE, Hardy SJ. Neurocognitive and psychological effects of persistent pain in pediatric sickle cell disease. Pediatr Blood Cancer. 2019;66(9):e27823. Doi:10.1002/pbc.27823 102. Leite MM, Santos MEFD, Fernandes JVA, Geovanini DR, Soares FC, Fonseca TCC, et al. Depressão em pacientes com doença falciforme: uma revisão de literatura. Hematol Transfus Cell Ther. 2024;46, S1139. Doi: 10.1016/j.htct.2024.09.1991 103. Castro MMC, Quarantini L, Batista-Neves S, Kraychete DC, Daltro C, MirandaScippa Â. Validade da escala hospitalar de ansiedade e depressão em pessoas com dor crônica. Rev Bras Anestesiol. 2006;56(5):470-7. Doi: 10.1590/S0034- 70942006000500005 104. Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, et al. PROMIS Cooperative Group. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item 112 banks: 2005-2008. J Clin Epidemiol. 2010;63(11):1179-94. Doi: 10.1016/j.jclinepi.2010.04.011 105. Ameringer S, Elswick RK Jr, Menzies V, Robins JL, Starkweather A, Walter J, et al. Psychometric evaluation of the patient-reported outcomes measurement information system fatigue-short form across diverse populations. Nurs Res. 2016;65(4):279-89. Doi: 10.1097/NNR.0000000000000162 106. Silva WS, Lopes TDSL, Reis DS, Barreto DPS, Silva GS, Oliveira TWS. Aspectos sociodemográficos e clínicos de pacientes com doenças falciformes dos centros de referência em Salvador, Bahia. BJHR. 2022;5(3):10526-39. Doi: 10.34119/bjhrv5n3-215 107. Fortunato JG, Furtado MS, Assis Hirabae LF, Oliveira JA. Escalas de dor no paciente crítico: uma revisão integrativa. Revista HUPE. 2013;12(3):110-7. Doi:10.12957/rhupe.2013.7538 108. Azevedo LF, et al. Tradução, adaptação cultural e estudo multicêntrico de validação de instrumentos para rastreio e avaliação do impacto da dor Crónica. IN: Dor® Questionários sobre Dor Crónica. Permanyer Portugal: APED – Associação Portuguesa para o Estudo da Dor [Internet]. 2007 [cited 2024 Dec 26];5(4):6-39. Avaiable from: https://www.aped-dor.org/socios/material_bibliografico/diversos_Questionarios_DorRev_DOR_Volume15-n4-2007.pdf 109. Toledo FO. Adaptação cultural do inventário breve da dor para a língua portuguesa no Brasil e teste de suas propriedades psicométricas [Internet]. 2008 [cited 2024 dez 22 ]. Dissertação (Mestrado) – Universidade de São Paulo, Ribeirão Preto. Available from: https://repositorio.usp.br/item/001655448 110. Ware Jr JE, Sherbourne CD. The MOS 36-ltem short-form health survey (SF-36): I. Conceptual framework and item selection. Medical care [Internet]. 1992 [cited 2024 Dec 19];30(6), 473-83. Available from: https://journals.lww.com/lwwmedicalcare/abstract/1992/06000/The_MOS_36_ltem_Short_Form_Health_Survey__S F_36__.2.aspx 111. Ware JE, Snow KK, Kosinski M, Gandek B. Manual e interpretação da pesquisa de saúde SF-36 [Internet]. 1993 [cited 2024 oct 16]. Available from: https://www.researchgate.net/profile/John-Ware-6/publication/313050850_SF36_Health_Survey_Manual_Interpretation_Guide/links/594a5b83aca2723195de5c3d/S F-36-Health-Survey-Manual-Interpretation-Guide.pdf 112. Botega NJ, Bio MR, Zomignani MA, Garcia Jr C, Pereira WAB. Transtornos do humor em enfermaria de clínica médica e validação de escala de medida (HAD) de ansiedade e depressão. Rev Saúde Pública. 1995;29(5):359-63. Doi: 10.1590/S0034- 89101995000500004 113 113. Alves FSM, Pinto RDMC, Mendonça TMS, Silva CHMD. Tradução e adaptação transcultural do domínio fadiga do Patient-Reported-Outcomes Measurement Information System (PROMIS) para a língua portuguesa. Cad Saúde Pública. 2014;30(5):1103-10. Doi: 10.1590/0102-311X00104513 114. Promis. Manual de pontuação de fadiga PROMIS. 2021[Internet]. National Institutes of Health (NIH) [cited 2024 oct 16]. Available from: https://www.healthmeasures.net/images/PROMIS/manuals/Scoring_Manuals_/PROMIS _Fatigue_Scoring_Manual.pdf 115. R Core Team (2024). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria 116. Dodo R, Zohoun A, Baglo T, Mehou J, Anani L. Emergency treatment of sickle cell diseases in the Blood Diseases Department at the Koutoukou Maga National Teaching Hospital, Cotonou, Benin. Pan Afr Med J. 2018;30:192. Doi: 10.11604/pamj.2018.30.192.15931118 117. Gioseffi JR, Simão FCDS, Melo NVM, Fróes E, Fedozzi F, Pinto CMF, Loggetto SR. Panorama da doença falciforme no Brasil (2012 A 2022). Hematol Transfus Cell Ther. 2024;46(4):S29. Doi: 10.1016/j.htct.2024.09.049 118. Myrvik MP, Drendel AL, Brandow AM, Yan K, Hoffmann RG, Panepinto JA. A comparison of pain assessment measures in pediatric sickle cell disease: visual analog scale versus numeric rating scale. J Pediatr Hematol Oncol. 2015;37(3):190-4. Doi: 10.1097/MPH.0000000000000306 119. Leão Lima KTL, Ferreira Pereira JO, Melo Reis PR, Correia de Alcântara K, Melo Rodrigues F. Qualidade de vida dos portadores de doença falciforme. Rev enferm UFPE on line. 2019;13(2): 424-30. Doi: 10.5205/1981-8963-v13i02a237424p424-430-2019 120. Bulgin D, Douglas C, Tanabe P. A pilot test of the adult sickle cell Quality of Life Measurement Information System (ASCQ-Me) and the Jenerette Self-Care Assessment (J-SAT) Tools in adults with sickle cell disease. Pilot Feasibility Stud. 2019;5(85):1-7. Doi:10.1186/s40814-019-0471-0 121. Olowoselu FO, Uche E, Oyedeji OA, Enabulele O, Ogunnubi OP, Olowoselu OI, et al. Anxiety and depression in sickle cell anaemia: the impact of pain in a Nigerian population. Nigerian Hospital Practice [Internet]. 2021 [cited 2024 Dec 28];27(1-2), 8- 14. Available from: https://www.ajol.info/index.php/nhp/issue/view/19571 122. Ameringer S, Elswick RK Jr, Smith W. Fatigue in adolescents and young adults with sickle cell disease: biological and behavioral correlates and health-related quality of life. J Pediatr Oncol Nurs. 2014;31(1):6-17. Doi: 10.1177/1043454213514632pt_BR
dc.type.degreeDoutoradopt_BR
Aparece nas coleções:Tese (PPGPIOS)

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
Tese - Leila Valverde Ramos.pdfTese12,64 MBAdobe PDFVisualizar/Abrir
Termo de aprovação - Defesa de tese.pdfTermo de aprovação - Defesa de tese145,63 kBAdobe PDFVisualizar/Abrir
Mostrar registro simples do item Visualizar estatísticas


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.